Wolverine Asset Management’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Wolverine Asset Management’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-652	Closed	-$190	–	2121
2023 Q3	$190	Hold	652	–	–	﹤0.01%	1804
2023 Q2	$317	Hold	652	–	–	﹤0.01%	1712
2023 Q1	$586	Hold	652	–	–	﹤0.01%	1748
2022 Q4	$801	Hold	652	–	–	﹤0.01%	1960
2022 Q3	$1K	Hold	652	–	–	﹤0.01%	2343
2022 Q2	$1K	Buy	+652	New	+$2.16K	﹤0.01%	2294

Wolverine Asset Management's CMRA Position: Q4 2023 in Review

Wolverine Asset Management sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 652 shares — an estimated $190 sold.

Wolverine Asset Management first reported a position in CMRA in Q2 2022 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

Wolverine Asset Management reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wolverine Asset Management sold 652 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $190.
Wolverine Asset Management first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Wolverine Asset Management's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $1K in Q3 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.